Rationale: Insight into the function of nuclear factor (NF)-B in the adult heart has been hampered by the embryonic lethality of constitutive NF-B inactivation. Objective: The goal of the present study was therefore to gain insights into the role of NF-B pathway specifically in mouse cardiomyocytes by conditional deletion of the NF-B essential modulator (NEMO). Methods and Results: Using a Cre/loxP system, we disrupted the Nemo gene in a cardiomyocyte-specific manner in the heart, which simulated gene expression changes underlying human heart failure and caused adult-onset dilated cardiomyopathy accompanied by inflammation and apoptosis. Pressure overload challenges of NEMOdeficient young hearts precociously induced the functional decrements that develop spontaneously in older knockout animals. Moreover, oxidative stress in NEMO-deficient cardiomyocytes is a critical pathological component that can be attenuated with antioxidant diet in vivo. Conclusions: These results reveal an essential physiological role for NEMO-mediated signaling in the adult heart to maintain cardiac function in response to age-related or mechanical challenges, in part through modulation of oxidative stress. (Circ Res. 2010;106:133-144.)
D ilated cardiomyopathy (DCM) is one of the major causes of sudden cardiac death. Patients with DCM develop ventricular dilation, impaired systolic function, and severe heart failure. 1 The etiology of DCM is multifactorial and many different clinical conditions can lead to the phenotype of DCM. Although it has become apparent that genetic factors play an important role in the pathogenesis of idiopathic DCM, the mechanisms by which mutations eventually result in clinical heart failure, are complex and not yet totally understood. 2, 3 Progression to DCM involves changes in the expression of multiple structural, calcium-regulator, and survival proteins, 4 reflecting the complexity of mechanisms underlying dilated heart failure.
In addition to its well-documented actions in the immune system, 5 mounting evidence implicates nuclear factor (NF)-B as a major player in various cardiac pathophysiological processes in humans, including ischemic preconditioning, 6 congestive heart failure, 7 unstable angina pectoris, 8 atherogenesis, 9 cardiac allograft rejection, 10 and apoptosis. 11 Yet the precise role of NF-B pathway in cardiac pathophys-iology has been disputed in the literature, [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] complicated by the fact that global inactivation of many pathway components either cause early embryonic lethality [22] [23] [24] or are functionally redundant. 25 Here, we have disrupted NF-B signaling in heart physiology by generating mice in which the NF-B essential modulator (Nemo) gene was conditionally ablated specifically in cardiomyocytes (Nemo hko ). NEMO or inhibitor of B kinase (IKK)␥ is the regulatory subunit of the IKK complex, a central component in NF-B activation that integrates a large number of stimuli. 26 The IKK complex also consists of 2 catalytic subunits, IKK1/IKK␣ and IKK2/IKK␤. 27 After IKK activation, the inhibitor of B (IB) is phosphorylated and degraded, allowing NF-B dimers to translocate to the nucleus, bind to their cognate DNA-binding sites, and regulate expression of genes involved in apoptosis, survival, proliferation, and immune responses. 28 NEMO inactivation in the heart did not affect embryonic cardiac development but led to spontaneous, progressive impairment of cardiac function in the adult and progression to DCM and heart failure attributable to oxidative stressmediated mechanisms. The Nemo hko genetic lesion also predisposed the heart to decompensation at earlier stages, because thoracic aortic banding of young Nemo hko mice triggered a rapid transition to dilation and heart failure. The spontaneous cardiac dysfunction in Nemo hko mice was partially relieved by antioxidant intervention, underscoring the critical role played by NF-B in countering the effects of oxidative stress and providing insight into the molecular mechanisms of DCM.
Methods

Aortic Banding
Transverse aortic banding (TAB) was performed in 9-to 12-weekold male control and Nemo hko mice (C57BL/6). Mice were anesthetized with 2% isoflurane and intubated in a Harvard Apparatus ventilator; a horizontal skin incision was made between intercostal 2 and 3, the aorta was isolated, and a 6.0 silk suture was snared with wire and pulled back around the aorta. A bent 25-gauge needle was then placed next to the aorta, and the suture was tied snugly around the needle and the aorta. After ligation, the needle was quickly removed, chest and skin were closed (using 8.0 silk suture), and mice were allowed to recover. All mouse procedures were approved by European Molecular Biology Laboratory (EMBL) Monterotondo Ethics Committee (Monterotondo, Italy) and were in accordance with national and European regulations.
Echocardiography Analysis
Animals were anesthetized with 2% isoflurane and the left hemithorax was shaved. The mice were placed on a temperaturecontrolled pad, and heart rate was continuously monitored (400 to 550 bpm). Ultrasound transmission gel (Parker Laboratories Inc) was used and the heart was imaged in the parasternal short-axis view. Two-dimensional B-mode images were obtained at the papillary muscle level using the Vevo 770 Ultrasound system (VisualSonics). Fractional shortening (FS) and left ventricular transversal area in diastole and systole were calculated using the Vevo 770 V2.2.3 software.
Antioxidant Treatment
The commonly used 2018 Global diet (Mucedola srl) was used as normal diet, whereas the antioxidant diet was the same 2018 Global diet only supplemented with 0.7% of the antioxidant compound butylated hydroxyanisole (BHA) (Sigma). Antioxidant food provided at 3 to 4 months of age and onwards. Both normal and antioxidant food were weighed every day to ensure similar food intake in all the experimental groups of the animals. Animals were kept in single cages to correlate food reduction in the cage with caloric intake for each mouse. All experiments were done according to the EMBL regulations that require continuous monitoring of the mice. Especially for the BHA experiment, mice were housed at the EMBL Phenotyping Core Facility and monitored using a video tracking-system to ensure similar activity. Water was provided daily in graduated bottles to monitor liquid reduction. Detailed monitoring of cardiac function by echocardiography was performed before and during the BHA treatment (6, 8, and 10 months). The experiment was terminated at 10 months of age and the hearts were examined at the histological and molecular level.
An expanded Methods section is available in the Online Data Supplement at http://circres.ahajournals.org.
Results
Heart-Specific Deletion of Nemo Blocks NF-B Activation
Mice constitutively lacking NEMO die during embryonic development. 29 To investigate the specific role of NEMO in the heart, we induced cardiac-specific disruption of the Nemo gene using ␣-MyHCCre-mediated loxP recombination (see the Online Data Supplement). Nemo hko animals were born and reached weaning age at the expected Mendelian frequency. Analysis of genomic DNA from various mouse tissues verified cardiac-specific Nemo gene ablation ( Figure  1A and Online Figure I ) and transcriptional analysis confirmed the efficient loss of Nemo gene expression in Nemo hko mice (Online Figure I, B ). Efficient ablation of the respective protein in whole Nemo hko heart extracts left the other subunits (IKK1 and IKK2) intact ( Figure 1B ), whereas expression levels of all IKK subunits were unchanged in other tissues ( Figure 1C ). Importantly, electrophoretic mobility-shift assay on steady-state or tumor necrosis factor (TNF)-␣-treated control and Nemo hko neonatal cardiomyocytes confirmed that NF-B binding activity to target sites was decreased 20 minutes after TNF-␣ stimulation in Nemo hko cardiomyocytes ( Figure 1D ), whereas IB␣ levels were elevated after the same stimulus ( Figure 1D and 1E).
Progressive Development of Cardiac Dilation in Nemo hko Mice
Analysis of hearts from 2-, 4-, and 6-month-old Nemo hko mice revealed no obvious abnormalities in cardiac morphology ( Figure 2A ). However, left atrium enlargement was evident in 8-month Nemo hko hearts ( Figure 2A ) and worsened at 10 months of age ( Figure 2B ), accompanied by anatomic features of eccentric hypertrophy, including dilation of the ventricular chambers and thinning of the myocardial wall ( Figure 2A , second and third sets of images). Heart weight/ body weight ratio measurements reflected the progressive development of pathological hypertrophy in Nemo hko animals ( Figure 2B ), whereas organ weight/body weight ratios for other organs (kidney, liver, lungs) were unaffected (data not shown). Cardiac dilation is often associated with extensive fibrosis of the cardiac muscle. 30 Eight-to 10-month-old Nemo hko hearts demonstrated extensive ventricular fibrosis ( Figure  2C ), as quantified by morphometric analysis ( Figure 2D ). Blood stasis in the left atrium of old Nemo hko hearts ( Figure   2A ; at 8 and 10-old-month hearts) could result in predisposition to thrombus formation in the atria. Indeed, Nemo hko hearts had dilated atria with extensive fibrosis (Figure 2E 
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Heart Failure Accompanies DCM in Old Nemo hko Mice
To assess cardiac function during the progressive pathology of Nemo hko animals, we performed echocardiography analysis on control and mutant littermates at different ages. No major differences were observed in the cardiac function of ␣-MyHC-Cre control mice (Online Figure II Two-dimensional M-mode images confirmed ventricular dilation and further demonstrated compromised cardiac contraction in Nemo hko animals at 8 and 10 months of age ( Figure 3B ). Increased expression of cardiac embryonic genes in the adult heart frequently indicates the onset of heart failure. 32 Quantitative RT-PCR clearly demonstrated a switch in the expression of the adult Myh6 and the embryonic Myh7 in 8-and 10-month-old Nemo hko hearts ( Figure 3C ). Additionally, the heart failure markers atrial natriuretic peptide (Anp), brain natriuretic peptide (Bnp), and actin ␣1 (Acta-1) were significantly upregulated in the heart of 8-and 10month-old ( Figure 3C ) Nemo hko animals, confirming progression to heart failure. Significant reduction in the expression of ryanodine receptor 2 (cardiac), SERCA2 (sarco-/endoplasmic reticulum Ca 2ϩ ATPase), Kcnd2 ( Figure 3D ), and of several other ion channels in 6-, 8-, and 10-month-old Nemo hko hearts (Online Figure V) suggested heart rhythm disturbance. Analysis of telemetric ECGs revealed that Nemo hko mice had an overall tendency to lower RR values (higher heart rates) as compared to control littermates and exhibited cardiac arrhythmias, consisting in ventricular premature beats and junctional escape beats associated with III degree AV block (Online Figure VI ). The first type of arrhythmia appeared in 3 of 12 recordings collected at 12 months of age. The second type of arrhythmia was observed in 2 of 12 recordings at 6 months of age and 5 of 12 recordings at 12 months of age. Taken together, the impaired cardiac function, the presence of arrhythmia, and the reactivation of the fetal gene program confirm the establishment of heart failure in Nemo hko animals.
Mechanically Stressed Nemo hko Hearts Develop Precocious Hypertrophy and Heart Failure
TAB is a widely used model for pressure overload-induced cardiac hypertrophy that eventually leads to ventricular dys-function and failure. 33, 34 To test whether Nemo gene inactivation predisposes the heart to failure under stress, young (2 to 3 month-old), Nemo hko mice were subjected to TAB. Heart dysfunction was evident as early as 2 weeks after the TAB operation, with significantly compromised FS (lower than 20%) in Nemo hko mice and left ventricular dilation ( Figure  4C ). Nemo hko animals developed higher heart weight/body weight ratio ( Figure 4B ) and severe fibrotic deposition in the atria (Figure 4A , lower images) and in the ventricles (data not shown). Higher levels of heart failure markers Anp, Bnp, and Myh7 expression ( Figure 4D ) confirmed severe cardiac remodeling 2 weeks after TAB. TUNEL analysis displayed a significant augmentation of TUNEL-positive cells (Figure 
Increased Apoptosis and Chemokine Production in Nemo hko Hearts
DCM has been associated with myocyte cell death. 35 Analysis of confocal images revealed increased numbers of TUNELpositive cells in both atria and ventricles of 8-to 10-month-old Nemo hko hearts when compared with Nemo fl/Y or ␣-MyHCCre hearts ( Figure 5A and 5B) . Consistently, increased staining for the activated form of caspase-3 was observed in the ventricles 8-to 10-month-old Nemo hko hearts ( Figure 5D ). Upregulation of the proapoptotic gene caspase-3 and downregulation of the antiapoptotic gene Bcl-XL (B-cell lymphoma-extra large) gene ( Figure 5C ) starting at 6 months of age, accompanied changes in the expression of other genes involved in cell death (Online Figure VII) . Moreover, assessment of cell viability in a primary cardiomyocyte culture model of oxygen/glucose deprivation (OGD) showed decreased sur- vival rate for the NEMO hko cells (Online Figure VIII) , further supporting the susceptibility of NEMO-deficient cardiomyocytes to stress conditions. Thus, disruption of NEMO-mediated signaling leads to impairment in the balance between apoptosis and antiapoptosis, demonstrating that the NEMO/NF-B pathway is critical for cell survival in the adult heart.
Myocardial dysfunction has been associated with inflammation, cytokine modulation and fibrotic tissue deposition. 36 Upregulation of TNF-␣, interleukin (IL)-6, intercellular adhesion molecule-1, and monocyte chemoattractant protein-2 ( Figure 6A ) was observed in the hearts of 6-month-old Nemo hko mice, suggesting that increased expression of proinflammatory cytokines and chemokines (also Online Figure  IX) is implicated in the observed DCM. Although the ␣-MyHC-Cre transgene expression is restricted to cardiomyocytes (Agah et al 37 and our unpublished data, 2009), immunohistochemical analysis showed increased TNF-␣ in noncardiomyocytes in Nemo hko hearts (Online Figure X) , suggesting that apoptosis might induce expression of cytokines and chemokines also in other cardiac cell types.
Antioxidant Treatment Ameliorates Cardiac Dysfunction in Old Nemo hko Hearts
Several lines of evidence implicate inflammation correlated with oxidative stress as the potential mechanisms for heart failure. 38, 39 The crucial role of oxidative stress in myocardial remodeling is underscored by in vivo studies in which mice deficient for antioxidant enzymes display ventricular dilation and increased apoptosis. 40, 41 Analysis of the expression levels of NF-B target genes known to have an antioxidant function 42, 43 revealed that the superoxide dismutase (SOD)2 and ferritin heavy chain (FHC) transcripts were significantly downregulated in 5-monthold Nemo hko hearts (Online Figure XI) , when there is no sign of cardiac disease, and remained downregulated at later life stages (Online Figure XI and Figure 6B ). Moreover, the transcript levels of SOD1, another gene associated with oxidative stress, 42 were also found to be decreased in 5-and 6-month-old Nemo hko hearts (Online Figure XI and Figure 6B ). In fact, markers associated with oxidative stress (SOD1, SOD2, and FHC) are affected in 5-month-old Nemo hko hearts (Online Figure XI) , whereas cytokine (TNF-␣, IL-6, intercellular adhesion molecule-1, and monocyte chemoattractant protein-2) levels are unaltered (Online Figure XII) and cardiac defects are not present, indicating that oxidative stress is a primary defect in the NEMO hko hearts. Additionally, staining for the 8-hydroxydeoxyguanosine (8-OHdG), a biomarker for measuring the effect of endogenous oxidative damage to DNA, 44 demonstrated increased numbers of 8-OHdG-positive nuclei in 6-month-old NEMO hko cardiac sections ( Figure 6C ), suggesting that Nemodeficient hearts have impaired antioxidant mechanisms, which may contribute to DCM.
To determine whether the deleterious effects of oxidative stress in the pathogenesis of heart failure in Nemo hko hearts could be attenuated, we subjected mice to an antioxidant diet (BHA) 45 starting at 3 to 4 months of age. Nemo hko mice on the antioxidant diet revealed improvement in ventricular dilation, as shown by histological analysis (Figure 7A) ; the heart weight/body weight ratio ( Figure 7B) , as well as the cardiomyocyte cross-sectional area ( Figure 7C) , was decreased when compared with Nemo hko mice on normal diet. Importantly, control animals fed BHA food did not show any effect (Figures 7 and 8) , confirming that BHA food by itself does not influence cardiac physiology. Furthermore, a statis- tically significant reduction in the left ventricular apoptotic index was observed in the Nemo hko mice on the antioxidant diet ( Figure 8A and 8B) , accompanied by a decrease in fibrotic tissue deposition ( Figure 8C ). Consequently, cardiac function was improved as observed by echocardiography in BHA fed Nemo hko mice at 8 and 10 months of age ( Figure 7D and 7E; Online Figure XIII, video) . Moreover, the expression levels of antioxidative stress genes (Online Figure XIV, A) , cytokines (Online Figure XIV, B) , apoptotic markers (Online Figure XV) , arrhythmia markers (Online Figure XVI) ,and heart failure markers (Online Figure XVII) were favorably modulated in the heart of NEMO hko animals fed a BHA diet, justifying a partial rescue of the DCM phenotype. Those findings demonstrate that oral administration of antioxidants can ameliorate the major aspects of age-related cardiac disease caused by disruption of NEMO/NF-B signaling, implying that oxidative stress is an important component of the cardiac dysfunction seen in this model.
Discussion
Because demographics clearly indicate a progressive increase in the population segment over 65 years of age, 46 the prolongation of heart strength and survival is a primary objective of present gene-and cell-based therapeutic approaches. Understanding the molecular mechanisms underlying the transition from normal cardiac function to heart failure is critical for the development of preventative thera-pies. The data presented here establish the transcription factor NF-B as an important modulator of normal cardiac function and associate blockade of NEMO/NF-B action in heart muscle with progression to cardiac dilation and failure, providing valuable insights in the pathogenesis of DCM and suggesting new targets for therapeutic intervention.
Various functions have been attributed to NF-B activation in the heart, including development of cardiac hypertrophy, 13, 16, 21 prevention of myocardial infarction, 19 and suppression of apoptosis in myocytes. 20 To date, mouse models have yielded conflicting evidence on the cardioprotective effects of NF-B signaling. Transgenic mice that overexpress TNF-␣ in cardiac myocytes exhibited progressive cardiac hypertrophy, chamber dilation, and heart failure. 17, 18 On the other hand, transgenic mice that express a phosphorylationresistant mutant of IB␣ in a cardiac-specific pattern showed normal cardiac morphology and histology, 47 whereas blockade of NF-B by eliminating the p50 subunit 12, 14, 15 or by expressing an IB␣ supersuppressor 48 ameliorated myocardial hypertrophy.
Using a Cre/loxP conditional knockout approach, the present study shows that blockade of NF-B function by ablation of upstream NEMO/IKK␥ signaling in cardiomyocytes results in spontaneous transition to DCM in the absence of hypertrophic stimuli, without the intermediate stage of compensated hypertrophy. NEMO-mediated activity is not required for cardiac development because Nemo hko mice are viable and fertile but rather is a key regulator of adult heart function. These findings reveal an unexpected physiological function of the NEMO/NF-B pathway in protecting animals from progressive cardiomyopathy and confirm that NEMO/ NF-B protective actions in the cardiomyocyte compartment are not solely age-related but are also essential in stress conditions, as demonstrated by ventricular dilation and upregulation of heart failure markers in young banded Nemo hko mice. Reduced cardiomyocyte survival in culture, as well as increased apoptosis in stressed young Nemo hko hearts, further supports the notion that NF-B deprivation in cardiomyocytes exacerbates both age-and stress-related decrements in cardiac function.
Our results are consistent with a 2-step model for the rapid progression toward heart failure in NEMO hko mice. Initially, the expression of the NF-B target antioxidative genes SOD2 and FHC is affected at 5-month-old NEMO hko hearts, a stage where no signs of cardiac pathology were observed, and it is accompanied later by DNA oxidization (increased 8-OHdG staining), suggesting that antioxidative mechanisms are impaired in NEMO hko hearts. Importantly, SOD2 knockout mice display oxidative mitochondrial injury in cardiomyocytes and develop DCM, 49, 50 whereas Sod2 gene polymorphisms have been associated with nonfamilial idiopathic DCM in humans, 51 providing further evidence that the NEMO/NF-B-Sod2 linkage may be one of the causes for the development of DCM in NEMO hko mice. As a second step in our model, we propose the increased expression of proinflammatory cytokines, such as IL-6 and TNF-␣, which was evident at 6-month-old Nemo hko hearts and not earlier. In fact, proinflammatory cytokines have been shown to depress myocardial mechanical function by enhancing oxidative stress in the heart, 52, 53 further suggesting that oxidative stress of NEMO-deficient cardiomyocytes was a critical step in the pathogenesis of this model.
Oxygen free radicals may cause dysfunction of the cardiovascular system through an increase in intracellular free Ca 2ϩ concentration and modulation of a variety of regulators such as Na ϩ and K ϩ ion exchangers. 54 Indeed, Nemo hko mice show a significant reduction in the calcium-handling transcripts ryanodine receptor 2 and Serca2, as well as in several ion exchangers such as Kcdn2 (Kc potassium ion channel gene 2), Kcnv2 (voltage-gated potassium [Kv] channel), Kcnip2, Tesc (Tescalcin), Sic28a2, and Trpc1 (transient receptor potential calcium ion channel, subfamily C, member 1), suggesting that the substrate for cardiac arrhythmia exists in these animals. Moreover, several in vivo studies demonstrate the involvement of oxidative stress in ventricular dilation and increased apoptosis. 40, 41 Accordingly, several markers of apoptosis (activated caspase-3, Bcl-XL, TUNEL), as well as ventricular dilation were evident in NEMO hko hearts. Furthermore, a recent study has demonstrated that downregulation of FHC causes oxidative stress and cell death in cardiomyocytes, 55 which is consistent with the observed downregulation of FHC mRNA in the NEMO hko hearts. These results demonstrate that in the absence of Nemo in cardiomyocytes of the adult heart a program of cell death and cardiac arrhythmia accompanies oxidative stress and is responsible for the adverse cardiac remodeling and heart failure observed in NEMO hko animals. Importantly, antioxidant regimen attenuated the progression of DCM, suggesting that other mechanisms or signaling pathways might be also contributing to the cardiac pathology seen in NEMO hko animals.
Because NF-B is an important mediator of physiological cardiac growth and function, our results raise important considerations for pharmacological therapies that target NF-B in heart disease patients. Although myocyte-specific ablation of the NF-B pathway resulted in improvements in skeletal muscle physiological function, reduced atrophy, and improved recovery from injury, 56, 57 the present study underscores the context dependence of NF-B function. In cardiomyocytes, persistent inhibition of NEMO/NF-B signaling is likely to be detrimental, leading to oxidative stress. Given the diverse effects of NF-B activation, restricting NF-B signaling in other noncardiomyocyte heart cell types could limit the inflammatory response and ameliorate cardiac function. More extensive research using cell-specific ablation will be necessary to evaluate the possible consequences of long-term cardiac NF-B inhibition in a clinical setting. under normal diet or after BHA diet (lower). Note that fibrosis of old Nemo hko hearts is present but significantly reduced in BHA fed animals. Quantification of fibrosis is shown below. *PϽ0.05, **PϽ0.01, ***PϽ0.001, significant difference between control and mutant mice (nϭat least 5 mice per genotype).
